ANCA Vasculitis: Symptoms, Causes, and Treatment Options

Normally, the human immune system is designed to be the first guardian of the human body and protect it from viruses, bacteria, and other harmful organisms. This system may sometimes malfunction and start damaging the tissues of the human body. One such complex autoimmune condition is ANCA vasculitis.

Although the term may appear to be medical jargon, it is important to learn more about this condition to understand it and its symptoms, which may not be explained by some causes and may persist despite ongoing efforts to address the problem. In this comprehensive guide, we will examine what this disease is, the symptoms to watch for, why it occurs, and how it is managed in modern medicine.

What is ANCA Vasculitis?

ANCA vasculitis is a group of rare autoimmune diseases characterised by the inflammation of small to medium-sized blood vessels. ANCA is the abbreviation used to mean Anti-Neutrophil Cytoplasmic Antibodies. They are defective antibodies generated by the immune system, which attacks the type of white blood cell known as neutrophils.

Once activated by antibodies, neutrophils adhere to blood vessel walls, resulting in inflammation (vasculitis). This inflammation may destroy the vessel walls, making them narrow or leaky, or they may develop scars. Because blood vessels transport oxygen and nutrients to all body organs, the condition may affect multiple organs simultaneously, with the kidneys, lungs, and nerves as typical examples.

The Different Types of ANCA Vasculitis

It is important to note that ANCA vasculitis is an "umbrella term" that covers three distinct but related conditions:

• Granulomatosis with Polyangiitis (GPA): This condition is also commonly referred to as Wegener granulomatosis and typically affects the upper respiratory tract (sinuses and nose), the respiratory organs (lungs), and the kidneys.
• Microscopic Polyangiitis (MPA): This type is mainly denser in the tiny blood vessels in the kidneys and lungs. In contrast to GPA, it typically does not require the formation of granulomas (aggregates of inflammatory cells).
• Eosinophilic Granulomatosis with Polyangiitis (EGPA) is also known as Churg-Strauss syndrome; in most cases, it is closely associated with asthma and elevated eosinophil counts (white blood cells).

Common Symptoms of ANCA Vasculitis

Because blood vessels are found throughout the body, the symptoms of ANCA vasculitis can be highly diverse and often mimic other, more common illnesses such as the flu or chronic allergies. This may occasionally complicate the initial diagnosis.

General or Systemic Symptoms

A significant number of patients initially have what are referred to as constitutional symptoms, the non-specific signs of an intra-bodily fight. These include:

• Chronic Fatigue: The feeling of exhaustion that cannot be relieved by rest.
• Fever and the Chills: Non-infectious low-grade fevers.
• Loss of Appetite and Weight Loss: Weight loss is a common early sign of disease.
• Muscle and Joint Pain: Generalised pain or stiffness, which is frequently misleading as early arthritis.

Organ-Specific Symptoms

The disease also develops symptoms which are more specific to the organ which has the most inflamed blood vessels:

• Respiratory System: Chronic pain in the sinus, frequent nosebleeds, or chronic cough. In severe cases, the patient may experience shortness of breath or cough up blood.
• Kidneys: Kidneys are frequently involved but are often silent in the early stages. It can be identified only by a urine test showing protein or blood. If left untreated, it may result in reduced kidney function and leg swelling (oedema).
• Skin: Visible skin changes are common in many patients, including purple or red spots (purpura), hives, or small ulcers.
• Nervous System: Nerves can be inflamed, causing numbness, tingling, or a pin-and-needle sensation in the hands and feet.

Causes and Risk Factors

The second common question patients ask is: Why did I get this? While medical science has made great strides, the exact cause of ANCA vasculitis remains a subject of ongoing research.

The Genetic and Environmental Interaction

It is not considered a hereditary disease in the traditional sense; you do not "inherit" it from your parents. Nevertheless, researchers hypothesise that certain individuals are genetically predisposed to immune dysfunction.

It is also believed that environmental triggers are of importance. The additional risk has been attributed to exposure to certain substances, e.g., silica dust (commonly present in construction work and mining activities). Moreover, viral or bacterial infections could serve as triggers that activate the autoimmune response in a patient already genetically predisposed.

How the ANCA Antibody Works

Antibodies are the soldiers in a healthy body that recognise and counterattack threats. The body produces ANCA in individuals with this disorder. These antibodies attack enzymes within the neutrophils. When the antibody binds to the neutrophil, it triggers the release of toxic substances and inflammatory signals by the neutrophil onto the blood vessel wall. This is the mechanism of disease, i.e. the friendly fire.

Treatment Options and Management

The goal of treating this autoimmune disease is to stop the inflammation as quickly as possible to prevent permanent organ damage. The treatment is usually divided into two phases.

Phase 1: Remission Induction Phase

This is the first phase, which is intensive and typically takes 3 to 6 months. It is targeted to settle the hyperactive immune system.

• Corticosteroids: Prednisone is frequently administered in high dosages to quickly deflame. Although effective, physicians gradually reduce the dose to minimise side effects.
• Immunosuppressants like Cyclophosphamide or Rituximab may be employed to inhibit the production of harmful ANCA antibodies. Among the biologic drugs, Rituximab is a favourite among many people because of its specific usage. 
• Plasmapheresis (Plasma Exchange): In severe cases of vasculitis, especially in cases of organ failures like the kidneys and lungs, plasma exchange may be performed. This is used to scan blood to physically eliminate harmful antibodies.

Phase 2: Remission Maintenance

Once the disease is under control, attention shifts to maintenance of control. The duration of this stage might take several years. Or such drugs as Azathioprine or Methotrexate are usually used because they are not as potent as induction drugs and still can serve to prevent various bursts (relapses).

Patients have a lifelong need to have their condition monitored regularly. Having regular blood tests and check-ups will ensure that, if the disease reactivates, it is treated before it causes significant damage.

Conclusion

Living with a chronic condition like ANCA vasculitis can feel overwhelming, but the outlook today is significantly better than it was just a few decades ago. With the help of early diagnosis and the use of modern immunosuppressive drugs, the majority of patients are able to achieve remission and lead normal, active lives. It is all a matter of being alert to symptoms, maintaining open communication with a rheumatologist, and adhering to the prescribed treatment plan.

Managing your health is not just about medical treatment; it is also about financial and emotional security. For those living abroad, navigating healthcare systems can be particularly stressful. If you are an Indian citizen living overseas, ensuring you have the right support is essential. It is highly recommended to explore Niva Bupa NRI Health Insurance, which offers comprehensive coverage tailored specifically for the needs of Non-Resident Indians. It provides assurance, ensuring that you and your family have access to quality healthcare in India without the burden of unexpected costs.

People Also Ask

1. Is ANCA vasculitis life-threatening?

Yes, ANCA vasculitis is life-threatening if it is not diagnosed and treated in time. Because inflammation of small blood vessels occurs with the disease, vital organs, in particular the kidneys and lungs, may sustain significant and severe injury within a short period. As an example, pulmonary haemorrhage (blood in the lungs) or acute kidney failure are severe conditions that need emergency treatment. Nevertheless, the mortality rate has tremendously decreased with modern developments in immunosuppressive treatment, and the majority of patients can experience a long-term remission when treated properly.

2. What Causes Vasculitis?

It is still not clear what exact causes vasculitis, but it falls into the first category of an autoimmune disease. This implies that the immune system attacks healthy blood vessels. It has been argued, according to research, that the interaction of several factors can cause this response:

• Genetic Predisposition: Certain genes may predispose individuals.
• Environmental Triggers: Exposure to certain chemical toxins (e.g., silica dust) or persistent infections can act as triggers.
• Immune System Errors: In the case of ANCA vasculitis, the production of specific antibodies (ANCA) causes white blood cells to attack the vessel walls directly.

3. Is it possible that you can live with vasculitis?

Although vasculitis is a chronic illness and needs to be monitored throughout their lifetime, a lot of individuals have been able to live full, productive, and normal lives with the attainment of remission. Therapy aims to bring the illness to a quiescent state, in which inflammatory activity is absent. In this phase, patients are generally able to resume work, physical activity, and other social activities. It, however, needs a new normal, which involves routine blood tests, visitation by a rheumatologist, and taking maintenance drugs to prevent the possibility of flares.

4. What is C-ANCA and P-ANCA?

These names are used to describe the two major patterns which are observed in the blood when they are testing these particular antibodies:

C-ANCA (Cytoplasmic): It is the most typical pattern of Granulomatosis with Polyangiitis (GPA). It normally attacks a protein known as Proteinase 3 (PR3).

P-ANCA (Perinuclear): P-ANCA is observed more commonly in patients of Microscopic Polyangiitis (MPA) or Eosinophilic Granulomatosis with Polyangiitis (EGPA). It normally attacks the Myeloperoxidase (MPO) enzyme. Being aware of the pattern type enables physicians to identify the specific subtypes of vasculitis and tailor the treatment plan accordingly.